Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration

Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration

Kyoko Okada, Mariko Kubota-Taniai, Masayasu Kitahashi, Takayuki Baba, Yoshinori Mitamura, Shuichi YamamotoDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanPurpose: To determine the correlation between the changes in the central retinal sensiti...

Full description

Bibliographic Details
Main Authors:	Kyoko Okada, Mariko Kubota-Taniai, Masayasu Kitahashi, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-09-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/changes-in-visual-function-and-thickness-of-macula-after-photodynamic--a3504

Similar Items

Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: Short-term results
by: Mitamura Yoshinori, et al.
Published: (2010-01-01)

Subretinal Hemorrhage after Photodynamic Therapy for Juxtapapillary Retinal Capillary Hemangioma
by: Takayuki Baba, et al.
Published: (2011-04-01)

PHOTODYNAMIC THERAPY OF MACULAR DEGENERATION
by: Davorin Sevšek, et al.
Published: (2004-05-01)

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
by: Takahashi H, et al.
Published: (2018-02-01)

Comparison of lucentis and photodynamic therapy in the treatment of wet age-related macular degeneration
by: Xin-Dan Wang, et al.
Published: (2014-03-01)

NORMAL FLUENCE PHOTODYNAMIC THERAPY ASSOCIATED WITH LAMELLAR MACULAR HOLES IN EXUDATIVE AGE RELATED MACULAR DEGENERATION
by: Alvaro Rodriguez, et al.
Published: (2014-09-01)

Authors′ reply
by: Mitamura Yoshinori, et al.
Published: (2010-01-01)

Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration
by: Simon J. Clark, et al.
Published: (2014-12-01)

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.
by: BC Reeves, et al.
Published: (2012-02-01)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
by: Jos&eacute; M&ordf; Ruiz-Moreno, et al.
Published: (2008-03-01)

Comparison of the visual outcome between macula-on and macula-off rhegmatogenous retinal detachment based on the duration of macular detachment
by: Daniel Kim, et al.
Published: (2021-07-01)

Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration
by: Elvan Alper Sengul, et al.
Published: (2017-05-01)

Optical coherence tomography changes on age-related macular degeneration patients after photodynamic therapy
by: Xiu-Mei Li, et al.
Published: (2014-06-01)

Evaluation of choroidal thickness in cases with age-related macular degeneration
by: Erkan Unsal, et al.
Published: (2014-09-01)

Macular Bruch's membrane defect and dome-shaped macula in high myopia.
by: Yuxin Fang, et al.
Published: (2017-01-01)

Photodynamic therapy combined with the Sanqi Panax Notoginseng for patients with age-related macular degeneration and choroidal neovascularization
by: Mei-Xia Song, et al.
Published: (2013-08-01)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
by: Tsuchihashi T, et al.
Published: (2013-03-01)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
by: Tomoko Nakamura, et al.
Published: (2012-01-01)

Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
by: Tsuchihashi T, et al.
Published: (2014-12-01)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
by: Azarmina Mohsen, et al.
Published: (2007-06-01)

Fellow eye in senile disciform degeneration of the macula
by: Azad Rajvardhan, et al.
Published: (1983-12-01)

Visual acuity and contrast sensitivity outcomes in Indian eyes undergoing photodynamic therapy with intravitreal injection of triamcinolone acetonide in age-related macular degeneration
by: Kumar Atul, et al.
Published: (2007-01-01)

Effect of Lucentis combined with photodynamic therapy on visual performance and sensitivity as well as serum VEGF levels in patients with wet age-related macular degeneration
by: Miao He, et al.
Published: (2016-09-01)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
by: Sakurai M, et al.
Published: (2014-01-01)

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
by: Min Ho Kim, et al.
Published: (2021-02-01)

Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
by: Ekta Rishi, et al.
Published: (2016-01-01)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
by: Jay Kumar Chhablani
Published: (2010-01-01)

Research status of photodynamic therapy combined anti-VEGF drugs to treat exudative age-related macular degeneration
by: Ling Li, et al.
Published: (2015-02-01)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
by: Mamdouh M Kabeel, et al.
Published: (2008-03-01)

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2015-08-01)

The enigma of visual function in age-related macular degeneration
by: Muldrew, K. A.
Published: (2005)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
by: Pukhraj Rishi, et al.
Published: (2011-02-01)

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up
by: Rosalia Giustolisi, et al.
Published: (2014-09-01)

Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
by: Tryfon Rotsos, et al.
Published: (2010-11-01)

Phacoemulsification Induced Changes of Choroidal Thickness in Eyes with Age-Related Macular Degeneration
by: Gailė Gudauskienė, et al.
Published: (2020-05-01)

Quantification of visual field loss in age-related macular degeneration.
by: Jennifer H Acton, et al.
Published: (2012-01-01)

Visual field and structural alterations in age-related macular degeneration
by: Acton, Jennifer H.
Published: (2010)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
by: Kabanarou SA, et al.
Published: (2017-05-01)

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
by: Tvenning AO, et al.
Published: (2019-02-01)

Photodynamic therapy and intravitreal bevacizumab with versus without triamcinolone for neovascular age-related macular degeneration; a randomized clinical trial
by: Niloofar Piri, et al.
Published: (2014-01-01)